Search
for
Sort by
Research 301–330 of 445
- THU0301 A Phase II Trial of Retinoids on Lupus Nephritis in A Single Center
- The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients
- P14 Mycophenolate mofetil in patients with autoimmune hepatitis intolerant to azathioprine
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- Budesonide for maintenance of remission in Crohn's disease
- Use of Silver in the Prevention and Treatment of Infections: Silver Review
- Mineral Malnutrition Following Bariatric Surgery
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Long-Term Effects of COVID-19
- Alopecia Areata: An Updated Review for 2023
- NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Treatment of pediatric alopecia areata: A systematic review
- Skin signs in anorexia nervosa
- Efficacy and safety of methotrexate in alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Direct Vasodilators and Sympatholytic Agents
- Sarcoidosis: Are there differences in your skin of color patients?
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology